MoneyWorks4Me

FDC - Quaterly Results

29 May 2024 Evaluate
The March 2024 quarter revenue stood at Rs. 4542.34 millions, up 5.34% as compared to Rs. 4311.96 millions during the corresponding quarter last year.An average growth of 29.41% was recorded for the quarter ended March 2024 to Rs. 481.95  millions from Rs. 372.41 millions.The company reported a good operating profit of 785.56 millions compared to 640.26 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 4542.34 4311.96 5.34 19161.87 17770.32 7.83 19161.87 17770.32 7.83
Other Income 207.16 101.48 104.14 1032.16 539.12 91.45 1032.16 539.12 91.45
PBIDT 785.56 640.26 22.69 4416.74 3084.87 43.17 4416.74 3084.87 43.17
Interest 9.44 11.47 -17.70 40.00 40.39 -0.97 40.00 40.39 -0.97
PBDT 776.12 628.79 23.43 4376.74 3044.48 43.76 4376.74 3044.48 43.76
Depreciation 103.95 96.90 7.28 397.29 387.58 2.51 397.29 387.58 2.51
PBT 672.17 531.89 26.37 3979.45 2656.90 49.78 3979.45 2656.90 49.78
TAX 190.22 159.48 19.28 907.82 647.25 40.26 907.82 647.25 40.26
Deferred Tax 58.22 11.48 407.14 51.63 -42.75 -220.77 51.63 -42.75 -220.77
PAT 481.95 372.41 29.41 3071.63 2009.65 52.84 3071.63 2009.65 52.84
Equity 162.81 165.91 -1.87 162.81 165.91 -1.87 162.81 165.91 -1.87
PBIDTM(%) 17.29 14.85 16.47 23.05 17.36 32.78 23.05 17.36 32.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..